ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

APLS Apellis Pharmaceuticals Inc

42.56
-0.66 (-1.53%)
After Hours
Last Updated: 08:58:28
Delayed by 15 minutes

Apellis Pharmaceuticals Financial Summary

The current APLS market cap is 5.13B. The company's latest EPS is USD -4.3591 and P/E is -9.77.

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 44.85M94.97M110.4M146.38M172.33M
Operating Income -175.08M-120.44M-137.08M-84.52M-62.09M
Net Income -177.78M-122.04M-140.24M-85.58M-66.42M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0250.65M66.56M75.42M396.59M
Operating Income -288.02M-213.73M-536.28M-594.61M-517.12M
Net Income -304.71M-344.87M-746.35M-652.17M-525.63M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 978.87M915.58M818.22M788.73M831.93M
Total Liabilities 566.75M570.18M585.95M594.21M565.25M
Total Equity 412.12M345.4M232.27M194.52M266.68M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 389.25M960.57M881.77M760.22M788.73M
Total Liabilities 355.02M756.01M683.1M590.35M594.21M
Total Equity 34.23M204.56M198.66M169.87M194.52M
Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -177.62M-327.78M-496.86M-594.74M-132.98M
Investing -259k-631k-678k-674k-293k
Financing 391.11M392.67M398.41M394.5M108.21M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -211.14M-160.49M-563.13M-513.75M-594.74M
Investing -1.69M-316.99M247.62M59.89M-674k
Financing 388.54M692.18M392.24M365.66M394.5M
Market Cap 5.13B
Price to Earnings Ratio -9.77
Price to Sales Ratio 12.95
Price to Cash Ratio 14.62
Price to Book Ratio 26.4
Dividend Yield -

Share Statistics

Shares Outstanding 120.58M
Average Volume (1 week) 1.48M
Average Volume (1 Month) 1.82M
52 Week Change -52.28%
52 Week High 94.75
52 Week Low 19.8301
Spread (Intraday) 0.96 (2.26%)

Company Info

Company Name Apellis Pharmaceuticals Inc
Address 108 lakeland ave
dover, delaware 19901
Website https://www.apellis.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock